Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Vlug is active.

Publication


Featured researches published by A. Vlug.


Journal of Clinical Investigation | 1992

On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

P.W.H.I. Parren; P. A. M. Warmerdam; Leonie C. M. Boeije; J. Arts; N. A. C. Westerdaal; A. Vlug; P. J. A. Capel; Lucien A. Aarden; J. G. J. Van De Winkel

An allotypic form of the low affinity IgG Fc receptor Fc gamma RIIa (CD32), termed low responder (LR) because of its weak reactivity with mouse (m) IgG1, interacts efficiently with human (h) IgG2. Fc gamma RIIaLR is the first known human FcR that binds this IgG subclass. In this study, we analyzed the role of Fc gamma RIIa in binding of stable hIgG-subclass dimers, and in induction of T cell mitogenesis using chimeric anti-CD3 mAb. We demonstrate that the functional polymorphism to hIgG2 is expressed on the majority of Fc gamma R-bearing peripheral blood cells: monocytes, neutrophils, and platelets. We were able to assess Fc gamma RII-mediated IgG-binding without interference of other Fc gamma R-classes, by blockade of Fc gamma RI on monocytes, and by using neutrophils of an individual deficient for the Fc gamma RIIIB gene. This study indicates as subclass specificity: hIgG3 >hIgG1,hIgG2 >> hIgG4 for Fc gamma RIIaLR and hIgG3,hIgG1 >> hIgG2 > hIgG4 for Fc gamma RIIaHR. Comparing the serum hIgG levels of individuals homozygous for the two fc gamma RIIa allotypic forms, we observed significantly lower hIgG2 serum levels in individuals expressing the hIgG2-binding LR allotypic form. This observation may implicate that Fc gamma RIIa regulates hIgG subclass production or turnover in man.


Scandinavian Journal of Immunology | 1987

Characterization of Two Fc Receptors for Mouse Immunoglobulins on Human Monocytes and Cell Lines

J. G. J. Van De Winkel; W.J.M. Tax; M.C.J. van Bruuggen; C.E.P. van Roozendaal; H.W. Willems; A. Vlug; P. J. A. Capel; R. A. P. Koene

We have previously reported a polymorphism in the mitogenic effect of murine (m) IgG1 anti‐CD3 monoclonal antibodies. This polymorphism was genetically determined and could be attributed to polymorphism of the Fc receptor (FcR) for mIgG1 present on human monocytes. We have now extended these studies by quantitating FcR expression on monocytes and cell lines by a recently developed EA rosette assay, using the erythrocyte‐associated pseudoperoxidase activity. The data show that the polymorphism of the monocyte FcR for mIgG1 is based on a quantitative rather than an absolute difference. Furthermore, this FcR is specific for mIgG1 and does not bind mIgG2a or mIgG2b nor, surprisingly, human IgG. The expression of this FcR on cell lines correlates with their accessory function in IgG1 anti‐CD3‐induced T cell proliferation. mIgG2a can inhibit the rosetting of monocytes with erythrocytes sensitized with human IgG. The FcR detected by this rosette technique can interact with all four human IgG subclasses but not with mIgG1 or mIgG2b. The expression of this type of FcR on human cell lines correlates well with their ability to support mIgG2a anti‐CD3‐induced mitogenesis. These direct measurements of FcR expression support the concept that human monocytes have two independent FcR with affinity for mouse IgG: one receptor specigic for mIgG2a (which also binds human IgG), and a second specific for mIgG1.


Journal of Immunology | 1991

A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding.

P. A. M. Warmerdam; J. G. J. Van De Winkel; A. Vlug; N. A. C. Westerdaal; P. J. A. Capel


Immunobiology | 1992

Polymorphism of the Human Fcγ Receptor II (CD32): Molecular Basis and Functional Aspects

Petra A.M. Warmerdam; Paul W. H. I. Parren; A. Vlug; Lucien A. Aarden; Jan G. J. van de Winkel; P. J. A. Capel


Journal of the National Cancer Institute | 1980

Naturally Occurring Leukemia Viruses in H-2 Congenic C57BL Mice. I. High Lymphoma Incidence Following Milk-Borne Transmission of Virus

C. J. M. Melief; A. Vlug; R. E. Y. de Goede; C. de Bruyne; W. Barendsen; P. de Greeve


Nature | 1979

Lymphocytotoxic antibodies produced by H-2 allo-immunisation distinguish between MuLV-positive and -negative substrains of the same H-2 haplotype.

Pavol Ivanyi; Cornelis J. M. Melief; Peter van Mourik; A. Vlug; Paul de Greeve


Journal of the National Cancer Institute | 1980

Naturally Occurring Leukemia Viruses in H-2 Congenic C57BL Mice. II. Antibody Response to Viral Envelope Antigens

A. Vlug; C. J. M. Melief; C. de Bruyne; H. Schoenmakers; J. L. Molenaar


International Journal of Cancer | 1983

H-2 control of the cytotoxic antibody response against a newly defined MuLV-related cell-surface antigen: G(B10.A)

A. Vlug; Maarten Zijlstra; Ruud E. Y. DeGoede; Wim G. Hesselink; Harrie J. Schoenmakers; Cornelis J. M. Melief


Archive | 2013

Protéine dimérique ayant des mutations triples

Jong Rob N. De; Frank Beurskens; Paul Parren; Aran Frank Labrijn; Janine Schuurman; A. Vlug; Sandra Verploegen


Scandinavian Journal of Immunology | 1989

Activity of 2 Types of Fc-Receptors, Fc-Gamma-Ri and Fc-Gamma-Rii, in Human Monocyte Cyto-Toxicity to Sensitized Erythrocytes

J. G. J. Van De Winkel; Ger J. J. C. Boonen; P.L.W. Janssen; A. Vlug; N. Hogg; W.J.M. Tax

Collaboration


Dive into the A. Vlug's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

W.J.M. Tax

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

H.W. Willems

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge